Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|March 16, 2026
Beyond drug delivery: nanoparticles as active modulators of immunometabolism for treating inflammatory diseasesHailing Wang, Ahequeli Gemingnuer, Yinan Wang, et al.
Biomedical Materials (Bristol, England)|July 31, 2025
Tumor-responsive nanomedicines for cancer therapy: design principles and therapeutic advancesYan Liu, Yinan Wang, Ahequeli Gemingnuer, et al.
Molecular Biology Reports|September 10, 2025
Lysosome-dependent cell death: disease implications and potential therapeutic targetsAhequeli Gemingnuer, Rui Yin, Yan Liu, et al.
Biogerontology|March 25, 2026
Polysaccharide-mediated aging-modulatory effects of Labisia Pumila extracts on the physiological changes in C. elegans and D. melanogasterYinan Wang, Ahequeli Gemingnuer, Xuemei Zhang, et al.
Nanoscale|April 22, 2026
Nanoparticle-mediated metabolic reprogramming for immune modulation in inflammatory diseasesHailing Wang, Ahequeli Gemingnuer, Yan Liu, et al.
Antiviral Research|July 3, 2026
Nanoparticles in viral pneumonia: diagnosis, therapy, and preventionRui Wu, Hailing Wang, Rui Yin, et al.
Annals of Biomedical Engineering|October 30, 2025
Carbon-Based Nanoplatforms in Diabetes: A New Paradigm in Diagnosis and TreatmentYao Jia, Yinan Wang, Hailing Wang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 11, 2025
Recent advances in novel targeting mechanisms for colorectal cancerZhiping Li, Hailing Wang, Yan Liu, et al.
Journal of Physiology and Biochemistry|February 27, 2026
Metabolic syndrome necroptosis: disease implications and therapeutic targetingJiaenli Bolati, Ahequeli Gemingnuer, Fang Lu, et al.
Molecular Biology Reports|March 3, 2026
Bacterial outer membrane vesicles as intrinsically immunogenic and highly modifiable nanocarriers for precision tumor therapyXue-Mei Zhang, Hai-Ling Wang, Ahequeli Gemingnuer, et al.
Pageof 1